Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Prophase Labs Inc PRPH

Healthcare Medical Care
ProPhase Labs, Inc. is a biopharma, genomics, and diagnostics company. The Company provides whole genome sequencing solutions, while developing potential diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Its... see more

Recent & Breaking News (NDAQ:PRPH)

ProPhase Labs Unveils Project ZenQ-AI

GlobeNewswire April 16, 2024

ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024

GlobeNewswire April 10, 2024

ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire April 1, 2024

ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives

GlobeNewswire March 15, 2024

PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024

GlobeNewswire March 8, 2024

ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART

GlobeNewswire February 20, 2024

ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir

GlobeNewswire February 14, 2024

ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics

GlobeNewswire January 30, 2024

Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts

GlobeNewswire January 23, 2024

ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024

GlobeNewswire January 4, 2024

ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023

GlobeNewswire November 9, 2023

ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time

GlobeNewswire November 2, 2023

ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.

GlobeNewswire October 17, 2023

DSS Inc. Issues Letter to Shareholders

GlobeNewswire October 12, 2023

ProPhase Labs to Present at The ThinkEquity Conference

GlobeNewswire October 12, 2023

ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.

GlobeNewswire August 10, 2023

ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2023

GlobeNewswire August 10, 2023

ProPhase Labs Teams up with Certis Oncology to Accelerate Development of Novel Linebacker Compound

GlobeNewswire August 3, 2023

ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time

GlobeNewswire August 2, 2023

Navidea Biopharmaceuticals Rejects ProPhase Labs Offer To Acquire Certain Assets of Navidea

GlobeNewswire June 29, 2023